Personality and Personality Disorders in Medication-Overuse Headache: A Controlled Study by SWAP-200

Federica Galli, Annalisa Tanzilli, Alessandra Simonelli, Cristina Tassorelli, Grazia Sances, Micol Parolin, Patrizia Cristofalo, Ivan Gualco, Vittorio Lingiardi, Federica Galli, Annalisa Tanzilli, Alessandra Simonelli, Cristina Tassorelli, Grazia Sances, Micol Parolin, Patrizia Cristofalo, Ivan Gualco, Vittorio Lingiardi

Abstract

Background: Medication-overuse headache (MOH) is a type of chronic headache, whose mechanisms are still unknown. The impact of psychological factors has been matter of debate from different perspectives. The role of personality and personality pathology in processes involved in MOH development has been advanced but was poorly studied. The hypothesis of addiction-like behaviors sustaining the drug misuse has been examined and reached contrasting findings.

Objectives: This study is aimed at detecting personality and its disorders (PDs) in MOH, with a specific attention to the addiction aspect.

Methods: Eighty-eight MOH patients have been compared with two clinical populations including 99 patients with substance use disorder (SUD) and 91 with PDs using the Shedler-Westen Assessment Procedure-200 (SWAP-200), a clinician-report tool that assesses both normal and pathological personality. MANCOVAs were performed to evaluate personality differences among MOH, SUD, and PD groups, controlling for age and gender.

Results: MOH patients were predominantly women and older. They showed lower traits of the SWAP-200's cluster A and B disorders than SUD and PD patients, who presented more severe levels of personality impairment. No differences in the SWAP-200's cluster C have been found, indicating common personality features in these populations. At levels of specific PDs, MOH patients showed higher obsessive and dysphoric traits and better overall psychological functioning than SUD and PD patients.

Conclusion: Although MOH, SUD, and PD populations have been evaluated in multiple sites with different levels of expertise, the study supported the presence of a specific constellation of personality in MOH patients including obsessive (perfectionist) and dysphoric characteristics, as well as good enough psychological resources. No similarities to drug-addicted and personality-disordered patients were found. Practitioners' careful understanding of the personality characteristics of MOH patients may be useful to provide a road map for the implementation of more effective treatment strategies and intervention programs.

References

    1. Mathew N. T., Stubits E., Nigam M. P. Transformation of episodic migraine into daily headache: analysis of factors. Headache: The Journal of Head and Face Pain. 1982;22(2):66–68. doi: 10.1111/j.1526-4610.1982.hed2202066.x.
    1. Headache classification Committee of the International Headache Society (IHS) The international classification of headache disorders, 3rd edition (beta version) Cephalalgia. 2013;33(9):629–808. doi: 10.1177/0333102413485658.
    1. Vandenbussche N. N., Laterza D., Lisicki M., et al. Medication-overuse headache: a widely recognized entity amidst ongoing debate. Journal of Headache and Pain. 2018;19(1):p. 50. doi: 10.1186/s10194-018-0875-x.
    1. Westergaard M. L., Hansen E. H., Glümer C., Olesen J., Jensen R. H. Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: a systematic review. Cephalalgia. 2014;34(6):409–425. doi: 10.1177/0333102413512033.
    1. Rapoport A., Stang P., Gutterman D. L., et al. Analgesic rebound headache in clinical practice: data from a physician survey. Headache. 1996;36(1):14–19. doi: 10.1046/j.1526-4610.1996.3601014.x.
    1. Bigal M. E., Serrano D., Buse D., Scher A., Stewart W. F., Lipton R. B. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache: The Journal of Head and Face Pain. 2008;48(8):1157–1168. doi: 10.1111/j.1526-4610.2008.01217.x.
    1. Thorlund K., Sun-Edelstein C., Druyts E., et al. Risk of medication overuse headache across classes of treatments for acute migraine. Journal of Headache and Pain. 2016;17(1):p. 107. doi: 10.1186/s10194-016-0696-8.
    1. Guidetti V., Galli F., Sheftell F. Headache attributed to psychiatric disorders. Handbook of Clinical Neurology. 2010;97:657–662. doi: 10.1016/s0072-9752(10)97055-3.
    1. Galli F., Patron L., Russo P. M., Bruni O., Strambi L. F., Guidetti V. Chronic daily headache in childhood and adolescence: clinical aspects and a 4-year follow-up. Cephalalgia. 2004;24(10):850–858. doi: 10.1111/j.1468-2982.2004.00758.x.
    1. Guidetti V., Galli F., Fabrizi P., et al. Headache and psychiatric comorbidity: clinical aspects and outcome in an 8-year follow-up study. Cephalalgia. 1998;18(7):455–462. doi: 10.1046/j.1468-2982.1998.1807455.x.
    1. Sances G., Galli F., Ghiotto N., et al. Factors associated with a negative outcome of medication-overuse headache: a 3-year follow-up (the ‘CARE’ protocol) Cephalalgia. 2013;33(7):431–443. doi: 10.1177/0333102413477737.
    1. Hagen K., Albretsen C., Vilming S. T., et al. A 4-year follow-up of patients with medication-overuse headache previously included in a randomized multicentre study. Journal of Headache and Pain. 2011;12(3):315–322. doi: 10.1007/s10194-010-0285-1.
    1. Merikangas K. R., Angst J., Isler H. Migraine and psychopathology. results of the Zurich cohort study of young adults. Archives of General Psychiatry. 1990;47(9):849–853. doi: 10.1001/archpsyc.1990.01810210057008.
    1. Galli F. Headache and anxiety/mood disorders: are we trapped in a cul-de-sac? Journal of Headache and Pain. 2017;18(1):p. 6. doi: 10.1186/s10194-016-0710-1.
    1. Wolf H. G. Personality features and reactions of subjects with migraine. Archives of Neurology and Psychiatry. 1937;37(4):895–921. doi: 10.1001/archneurpsyc.1937.02260160195019.
    1. Dixon-Gordon K. L., Conkey L. C., Whalen D. J. Recent advances in understanding physical health problems in personality disorders. Current Opinion in Psychology. 2018;21:1–5. doi: 10.1016/j.copsyc.2017.08.036.
    1. Naylor B., Boag S., Gustin S. M. New evidence for a pain personality? A critical review of the last 120 years of pain and personality. Scandinavian Journal of Pain. 2017;17(1):58–67. doi: 10.1016/j.sjpain.2017.07.011.
    1. Cloninger C. R. The Temperament and Character Inventory (TCI): A Guide to its Development and Use. St. Louis, MO, USA: Center for Psychobiology of Personality, Washington University; 1994.
    1. Abbate-Daga G., Fassino S., Lo Giudice R., et al. Anger, depression and personality dimensions in patients with migraine without aura. Psychotherapy and Psychosomatics. 2007;76(2):122–128. doi: 10.1159/000097971.
    1. Boz C., Gazioglu S., Altunayoglu V., Hocaoglu C. Effect of serotonergic antidepressant therapy on temperament and character scales in patients with chronic tension-type headache. Psychiatry and Clinical Neurosciences. 2007;61(5):534–542. doi: 10.1111/j.1440-1819.2007.01704.x.
    1. Nylander P.-O., Schlette P., Brändström S., et al. Migraine: temperament and character. Journal of Psychiatric Research. 1996;30(5):359–368. doi: 10.1016/0022-3956(96)00009-x.
    1. Sánchez-Román S., Téllez-Zenteno J. F., Zermeño-Phols F., et al. Personality in patients with migraine evaluated with the “Temperament and Character Inventory”. Journal of Headache and Pain. 2007;8(2):94–104. doi: 10.1007/s10194-007-0352-9.
    1. Yang F., Dos Santos I. A. M., Gomez R. S., Kummer A., Barbosa I. G., Teixeira A. L. Personality disorders are associated with more severe forms of migraine. Acta Neurologica Belgica. 2018:1–5. doi: 10.1007/s13760-018-1050-5.
    1. Bigal M. E., Sheftell F. D., Rapoport A. M., Tepper S. J., Weeks R., Baskin S. M. MMPI personality profiles in patients with primary chronic daily headache: a case-control study. Neurological Sciences. 2003;24(3):103–110. doi: 10.1007/s10072-003-0094-2.
    1. Butcher J. N., Graham J. R., Tellegen A., Kaemmer B. Manual for the restandardized Minnesota Multiphasic Personality Inventory: MMPI-2. Minneapolis, MN, USA: University of Minnesota; 1989.
    1. First M. B., Gibbon M., Spitzer R. L., Williams J. B. W., Benjamin L. S. Structured Clinical Interview for DSM-IV Axis II Personality Disorders, (SCID-II) Washington, DC, USA: American Psychiatric Press; 1997.
    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th. Washington, DC, USA: American Psychiatric Publishing; 1994.
    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th. Washington, DC, USA: American Psychiatric Publishing; 2013.
    1. Atasoy H. T., Atasoy N., Unal A. E., Emre U., Sumer M. Psychiatric comorbidity in medication overuse headache patients with pre-existing headache type of episodic tension-type headache. European Journal of Pain. 2005;9(3):p. 285. doi: 10.1016/j.ejpain.2004.07.006.
    1. Kayhan F., Ilik F. Prevalence of personality disorders in patients with chronic migraine. Comprehensive Psychiatry. 2016;68:60–64. doi: 10.1016/j.comppsych.2016.04.007.
    1. Quirk S. E., Stuart A. L., Brennan-Olsen S. L., et al. Physical health comorbidities in women with personality disorder: data from the Geelong osteoporosis study. European Psychiatry. 2016;34:29–35. doi: 10.1016/j.eurpsy.2015.12.007.
    1. Fuh J. L., Wang S. J., Lu S. R., Juang K. D. Does medication overuse headache represent a behavior of dependence? Pain. 2005;119(1–3):49–55. doi: 10.1016/j.pain.2005.09.034.
    1. Radat F., Creach C., Guegan-Massardier E., et al. Behavioral dependence in patients with medication overuse headache: a cross-sectional study in consulting patients using the DSM-IV criteria. Headache: The Journal of Head and Face Pain. 2008;48(7):1026–1036. doi: 10.1111/j.1526-4610.2007.00999.x.
    1. Cargnin S., Viana M., Sances G., Tassorelli C., Terrazzino S. A systematic review and critical appraisal of gene polymorphism association studies in medication-overuse headache. Cephalalgia. 2018;38(7):1361–1373. doi: 10.1177/0333102417728244.
    1. Lai T. H., Wang S. J. Neuroimaging findings in patients with medication overuse headache. Current Pain and Headache Reports. 2018;2(1):p. 1. doi: 10.1007/s11916-018-0661-0.
    1. Chong C. D., Schwedt T. J., Hougaard A. Brain functional connectivity in headache disorders: a narrative review of MRI investigations. Journal of Cerebral Blood Flow & Metabolism. 2017;39(4):650–669. doi: 10.1177/0271678x17740794.
    1. Galli F., Pozzi G., Frustaci A., et al. Differences in the personality profile of medication-overuse headache sufferers and drug addict patients: a comparative study using MMPI-2. Headache: The Journal of Head and Face Pain. 2011;51(8):1212–1227. doi: 10.1111/j.1526-4610.2011.01978.x.
    1. Love A. W., Peck C. L. The MMPI and psychological factors in chronic low back pain: a review. Pain. 1987;28(1):1–12. doi: 10.1016/0304-3959(87)91054-2.
    1. Bornstein R. F. Behaviorally referenced experimentation and symptom validation: a paradigm for 21st-century personality disorder research. Journal of Personality Disorders. 2003;17(1):1–18. doi: 10.1521/pedi.17.1.1.24056.
    1. Westen D., Shedler J. Revising and assessing axis II, part I: developing a clinically and empirically valid assessment method. American Journal of Psychiatry. 1999;156(2):258–272. doi: 10.1176/ajp.156.2.258.
    1. Westen D, Shedler J. Revising and assessing axis II, part II: Toward an empirically based and clinically useful classification of personality disorders. American Journal of Psychiatry. 1999;156(2):273–285.
    1. Shedler J., Westen D. Refining personality disorder diagnosis: integrating science and practice. American Journal of Psychiatry. 2004;161(8):1350–1365. doi: 10.1176/appi.ajp.161.8.1350.
    1. Shedler J., Westen D. The Shedler–Westen Assessment Procedure (SWAP): making personality diagnosis clinically meaningful. Journal of Personality Assessment. 2007;89(1):41–55. doi: 10.1080/00223890701357092.
    1. Shedler J., Westen D., Lingiardi V. The Evaluation of Personality with the SWAP-200. Milan, Italy: Raffaello Cortina Publisher; 2014.
    1. Block J. The Q–Sort Method in Personality Assessment and Psychiatric Research. Palo Alto, CA, USA: Consulting Psychologists Press; 1978.
    1. Blagov P. S., Bi W., Shedler J., Westen D. The Shedler-Westen assessment procedure (SWAP): evaluating psychometric questions about its reliability, validity, and impact of its fixed score distribution. Assessment. 2012;19(3):370–382. doi: 10.1177/1073191112436667.
    1. Westen D., Shedler J. Personality diagnosis with the Shedler-Westen assessment procedure (SWAP): integrating clinical and statistical measurement and prediction. Journal of Abnormal Psychology. 2007;116(4):810–822. doi: 10.1037/0021-843x.116.4.810.
    1. Westen D., Muderrisoglu S. Clinical assessment of pathological personality traits. American Journal of Psychiatry. 2006;163(7):1285–1287. doi: 10.1176/appi.ajp.163.7.1285.
    1. Westen D., Weinberger J. When clinical description becomes statistical prediction. American Psychologist. 2004;59(7):595–613. doi: 10.1037/0003-066x.59.7.595.
    1. Kristoffersen E. S., Lundqvist C. Medication-overuse headache: epidemiology, diagnosis and treatment. Therapeutic Advances in Drug Safety. 2014;5(2):87–99. doi: 10.1177/2042098614522683.
    1. Sances G., Galli F., Anastasi S., et al. Medication-overuse headache and personality: a controlled study by means of the MMPI-2. Headache: The Journal of Head and Face Pain. 2010;50(2):198–209. doi: 10.1111/j.1526-4610.2009.01593.x.
    1. Rothrock J., Lopez I., Zweilfer D., Andress-Rothrock D., Drinkard R., Walters N. Borderline personality disorder and migraine. Headache: The Journal of Head and Face Pain. 2007;47(1):22–26. doi: 10.1111/j.1526-4610.2007.00649.x.
    1. Campbell G., Bruno R., Darke S., Degenhardt L. Associations of borderline personality with pain, problems with medications and suicidality in a community sample of chronic non-cancer pain patients prescribed opioids for pain. General Hospital Psychiatry. 2015;37(5):434–440. doi: 10.1016/j.genhosppsych.2015.05.004.
    1. Köck P., Walter M. Personality disorder and substance use disorder—an update. Mental Health & Prevention. 2018;12:82–89. doi: 10.1016/j.mhp.2018.10.003.
    1. Calabresi P., Cupini L. M. Medication-overuse headache: similarities with drug addiction. Trends in Pharmacological Sciences. 2005;26(2):62–68. doi: 10.1016/j.tips.2004.12.008.
    1. Sarchielli P., Corbelli I., Messina P., et al. Psychopathological comorbidities in medication-overuse headache: a multicentre clinical study. European Journal of Neurology. 2016;23(1):85–91. doi: 10.1111/ene.12794.
    1. Goldman D., Oroszi G., Ducci F. The genetics of addictions: uncovering the genes. Nature Reviews Genetics. 2005;6(7):521–532. doi: 10.1038/nrg1635.
    1. Kendler K. S., Chen X., Dick D., et al. Recent advances in the genetic epidemiology and molecular genetics of substance use disorders. Nature Neuroscience. 2012;15(2):181–189. doi: 10.1038/nn.3018.
    1. Khantzian E. J. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harvard Review of Psychiatry. 1997;4(5):231–244. doi: 10.3109/10673229709030550.
    1. Thorberg F. A., Lyvers M. Attachment in relation to affect regulation and interpersonal functioning among substance use disorder in patients. Addiction Research & Theory. 2010;18(4):464–478. doi: 10.3109/16066350903254783.
    1. Grant B. F., Saha T. D., Ruan W. J., et al. Epidemiology of DSM-5 drug use disorder: results from the national epidemiologic survey on alcohol and related conditions–III. Journal of the American Medical Association Psychiatry. 2017;73(1):39–47. doi: 10.1001/jamapsychiatry.2015.0584.
    1. Jacobsen L. K., Southwick S. M., Kosten T. R. Substance use disorders in patients with posttraumatic stress disorder: a review of the literature. American Journal of Psychiatry. 2001;158(8):1184–1190. doi: 10.1176/appi.ajp.158.8.1184.
    1. Lai H. M. X., Cleary M., Sitharthan T., Hunt G. E. Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: a systematic review and meta-analysis. Drug and Alcohol Dependence. 2015;154:1–13. doi: 10.1016/j.drugalcdep.2015.05.031.
    1. Hilsenroth M. J., Katz M., Tanzilli A. Psychotherapy research and the psychodynamic diagnostic manual (PDM-2) Psychoanalytic Psychology. 2018;35(3):320–327. doi: 10.1037/pap0000207.
    1. Lingiardi V., McWilliams N. The psychodynamic diagnostic manual—2nd edition (PDM-2) World Psychiatry. 2015;14(2):237–239.
    1. Berkson J. Limitations of the application of fourfold table analysis to hospital data. Biometrics Bulletin. 1946;2(3):47–53. doi: 10.2307/3002000.
    1. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd. Hillsdale, NJ, USA: Erlbaum; 1988.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit